TissueLabs is a Swiss biopharma and biotechnology startup founded in 2019. With the slogan "The platform for creating organs and tissues in the lab," this innovative company has garnered significant attention within the industry. In its most recent funding round on 22 March 2024, TissueLabs secured an impressive $800.00K in a Pre Seed Round, attracting investments from MIT Alumni Angels and Mergus Ventures.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Pre Seed Round | $800.00K | 2 | 22 Mar 2024 | |
Pre Seed Round | $200.00K | 1 | 05 Jan 2023 | |
Grant | BRL1.00M | 1 | Fundação de Amparo à Pesquisa do Estado de SP | 01 Feb 2022 |
Grant | Fr.15.00K | 1 | 12 Sep 2021 | |
Non Equity Assistance | Unknown | 1 | MassChallenge Switzerland | 17 May 2021 |
No recent news or press coverage available for TissueLabs.